SCHEMBL1727771

SCHEMBL1727771

O=S(=O)(NC(CO)CCO)c1ccc(F)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC1A3 P43003 1/20 0.50
▸ SLC1A2 P43004 1/20 0.50
▸ SLC1A1 P43005 1/20 0.50
▸ MMP2 P08253 4/20 0.49
▸ MMP9 P14780 4/20 0.49
▸ CA1 P00915 4/20 0.49
▸ CA2 P00918 4/20 0.49
▸ MMP1 P03956 3/20 0.49
▸ MMP13 P45452 3/20 0.49
▸ MMP8 P22894 3/20 0.49
▸ MMP3 P08254 2/20 0.44
▸ MMP7 P09237 2/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ PKM P14618 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ MMP14 P50281 2/20 0.43
▸ TDO2 P48775 2/20 0.43
▸ EGFR P00533 1/20 0.43
▸ ERBB2 P04626 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2216960 1.00 SLC1A3 (0.50) SLC1A3SLC1A2SLC1A1MMP2MMP9
SCHEMBL29831100 0.84 CA2 (0.54) SLC1A3SLC1A2SLC1A1MMP2MMP9
SCHEMBL7568069 0.84 CA2 (0.54) SLC1A3SLC1A2SLC1A1MMP2MMP9
SCHEMBL6321585 0.77 TDO2 (0.61) SLC1A3SLC1A2SLC1A1MMP2MMP9
SCHEMBL6321590 0.77 TDO2 (0.61) SLC1A3SLC1A2SLC1A1MMP2MMP9
SCHEMBL1287356 0.76 CA1 (0.53) SLC1A3SLC1A2SLC1A1MMP2MMP9
SCHEMBL7845236 0.76 FFAR1 (0.44) SLC1A3SLC1A2SLC1A1MMP2MMP9
SCHEMBL16005166 0.74 MMP2 (0.61) SLC1A3SLC1A2SLC1A1MMP2MMP9
SCHEMBL28042871 0.74 MMP2 (0.61) SLC1A3SLC1A2SLC1A1MMP2MMP9
SCHEMBL12169313 0.73 CA2 (0.65) SLC1A3SLC1A2SLC1A1MMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2346865-B1 INDOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS MERCK CANADA INC (CA) 2015-07-15 — — EP disclosed
EP-2344497-A1 AZAINDOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS Merck Frosst Canada Ltd. (CA) 2011-07-20 — — EP disclosed
WO-2010031183-A1 INDOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS MERCK FROSST CANADA LTD. (CA) 2010-03-25 — — WO disclosed
WO-2010031184-A1 AZAINDOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS MERCK FROSST CANADA LTD. (CA) 2010-03-25 — — WO disclosed
Send feedback